Company intelligence / Profile preview

Vivia Biotech

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Vivia Biotech is a preclinical and translational CRO that develops ex vivo assays on patient samples to generate clinically relevant data for oncology and autoimmune drug development[2]. The company has over 15 years of experience with 100+ pharmaceutical and biotech collaborations and an 80% returning client rate[4]. Their PharmaFlow PM companion diagnostic test has demonstrated over 90% complete remission rates[8].

Therapeutic areas: OncologyImmunologyNeurologyHematology
Modalities: Ex vivo assays
Industry: Contract Research Organization

Partnerships

9 of the 10 top pharmaceutical companies worldwide have collaborated with them[3]

Beyond the preview

Go deeper on Vivia Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vivia Biotech.